(Q34131680)

31 July 2017

8 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

20 August 2019

12 September 2019

12 October 2019

26 January 2021

Neuroprotection in acute ischemic stroke--current status (English)

1 reference

31 July 2017

7 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

20 August 2019

12 September 2019

12 October 2019

7 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

20 August 2019

12 September 2019

12 October 2019

cerebrovascular disease

3 references

22 March 2019

25 April 2019

17 June 2019

physiological phenomenon

1 reference

20 August 2019

1 reference

12 September 2019

1 reference

12 October 2019

neuroprotective agent

1 reference

26 January 2021

E Auriel

1

1 reference

31 July 2017

N M Bornstein

series ordinal

2

1 reference

31 July 2017

publication date

1 September 2010

9 references

Journal of Cellular and Molecular Medicine

31 July 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

20 August 2019

12 September 2019

12 October 2019

26 January 2021

9 references

31 July 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

20 August 2019

12 September 2019

12 October 2019

26 January 2021

14

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

2200-2202

1 reference

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Neuroprotection does not work!

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Neuroprotection: still achievable in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

The past and future of neuroprotection in cerebral ischaemic stroke

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

1,026 experimental treatments in acute stroke

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Time Is Brain--Quantified

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

The dynamics of cellular injury: transformation into neuronal and vascular protection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Biology of ischemic cerebral cell death

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Drug development for stroke: importance of protecting cerebral white matter

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2010.01135.X

A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3822558

Using pathophysiology in acute stroke trials

28 October 2018

1 reference

12 December 2020

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

1 reference

12 December 2020

Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design

1 reference

12 December 2020

Neuroprotection for acute stroke: making clinical trials work

1 reference

12 December 2020

10.1111/J.1582-4934.2010.01135.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference